“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...

For years, a diagnosis of colon cancer meant potential surgery followed by a painful round of chemotherapy to kill the remaining cancer cells. One-size-fits-all treatment was normal. A new blood test ...

Defining cure in stage II and III colon cancer has been challenging, and has never been systematically studied. In an analysis of 15 randomized trials, colon cancer relapse risk fell to 0.5% by year 6 ...

The University of Wisconsin–Madison and Immuto Scientific have teamed up to explore new therapeutic targets in colorectal ...

The U.S. FDA has granted fast track status to pelareorep combination therapy for some KRAS-mutant, microsatellite-stable metastatic colorectal cancers.

Researchers at Åbo Akademi University have identified a new molecular change in patients with colorectal cancer and developed a genetic disease model that forms tumors in the large intestine, ...

CINCINNATI, Ohio. (Ivanhoe Newswire) — Rectal cancer cases are climbing in the U.S., now striking almost 47,000 people every year. When you add all types of colorectal cancer, that number soars past ...

There will be over 150,000 new colorectal cancer diagnoses this year - and it’s impacting more young people - Colorectal ...

Researchers note that toxin appeared to concentrate its effects within tumour tissue and did not cause any harmful ...